| NCT05761561 |
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer |
| NCT06066437 |
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial |
| NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
| NCT06529822 |
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease |
| NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
| NCT05784688 |
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors |
| NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
| NCT07166094 |
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer |
| NCT06620627 |
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection |
| NCT06062745 |
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT |
| NCT03824145 |
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer |
| NCT05005403 |
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan |
| NCT07028853 |
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. |
| NCT06524973 |
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers |
| NCT05629494 |
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test |
| NCT05413850 |
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection |
| NCT05806931 |
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer |
| NCT07702032 |
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) |
| NCT06106477 |
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer |
| NCT07288112 |
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma |
| NCT06225011 |
Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer |
| NCT06757634 |
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) |
| NCT07075731 |
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy |
| NCT06937177 |
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy |
| NCT05248581 |
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases |
| NCT03556228 |
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma |
| NCT06128551 |
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors |
| NCT05950945 |
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer |
| NCT06824467 |
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) |
| NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
| NCT06466434 |
Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma |
| NCT05803941 |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
| NCT06121453 |
Adherence Intervention in Patients With Metastatic Breast Cancer |
| NCT04075305 |
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study |
| NCT07032545 |
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors |
| NCT06040970 |
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer |
| NCT06855277 |
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC |
| NCT07228000 |
Bundled Cancer Screening and Genetic Services Navigation |
| NCT05542407 |
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer |
| NCT07587957 |
Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors |
| NCT05655312 |
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma |
| NCT07185165 |
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. |
| NCT07227038 |
Living Well With Advanced Breast Cancer |
| NCT02250352 |
Core Biopsies for Establishing a Breast Tumor Tissue Repository |
| NCT07488676 |
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors |
| NCT06698146 |
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection |
| NCT07337590 |
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar |
| NCT05040360 |
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors |
| NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
| NCT07082920 |
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer |
| NCT07790718 |
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer |
| NCT05624918 |
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma |
| NCT07332000 |
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec |
| NCT04852887 |
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) |
| NCT07141121 |
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen |
| NCT07621614 |
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information |
| NCT00843375 |
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas |
| NCT05667532 |
The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts |
| NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
| NCT07062965 |
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. |
| NCT07223411 |
Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma |
| NCT04895709 |
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors |
| NCT06423963 |
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer |
| NCT03943316 |
Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer |
| NCT06244771 |
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors |
| NCT06555133 |
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC |
| NCT05559164 |
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted |
| NCT07354919 |
Axelopran for Advanced Cancer in Patients Receiving Opioids |
| NCT07214532 |
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer |
| NCT05824975 |
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) |
| NCT06315595 |
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI |
| NCT07409272 |
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer |
| NCT06989437 |
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue |
| NCT07319195 |
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) |
| NCT07436637 |
Guardant Shield Colorectal Cancer Screening |
| NCT06997029 |
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors |
| NCT03906253 |
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia |
| NCT07659795 |
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer |
| NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
| NCT05633654 |
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) |
| NCT05253651 |
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer |
| NCT02595957 |
Genomic Services Research Program |
| NCT06833853 |
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients |
| NCT04779554 |
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC |
| NCT06750094 |
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy |
| NCT05848141 |
Rowing Following Breast Cancer Chemotherapy |
| NCT07405086 |
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study |
| NCT07181161 |
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer |
| NCT06898996 |
FITting Non-invasive Tests in Lynch Syndrome Surveillance |
| NCT05910294 |
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer |
| NCT06380751 |
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer |
| NCT07075705 |
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy |
| NCT05984888 |
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer |
| NCT05946824 |
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. |
| NCT07764796 |
Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya |
| NCT06623396 |
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer |
| NCT06172283 |
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
| NCT07278986 |
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer |
| NCT06896162 |
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival |
| NCT07276386 |
Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma |
| NCT04567706 |
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma |
| NCT07220135 |
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer |
| NCT05256225 |
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma |
| NCT05779423 |
Cryoablation+Ipilimumab+Nivolumab in Melanoma |
| NCT06615752 |
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients |
| NCT04907643 |
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
| NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
| NCT07569926 |
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence |
| NCT05997615 |
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer |
| NCT06582615 |
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer |
| NCT07198724 |
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer |
| NCT07237594 |
IL-17 Blockade to Decrease irAEs (REPLAY) |
| NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
| NCT06862856 |
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence |
| NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
| NCT07146568 |
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital |
| NCT05343013 |
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy |
| NCT07211659 |
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients |
| NCT07070726 |
UNTOLD Ovarian Cancer Unmet Needs Survey |
| NCT06374459 |
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis |
| NCT07556380 |
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions |
| NCT07324096 |
A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer |
| NCT04751396 |
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors |
| NCT06696768 |
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer |
| NCT05568680 |
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma |
| NCT00001276 |
Diagnosing and Treating Low Blood Sugar Levels |
| NCT06397703 |
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer |
| NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
| NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
| NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
| NCT02997709 |
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients |
| NCT05187832 |
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer |
| NCT07635238 |
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer |
| NCT05267626 |
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer |
| NCT02526368 |
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer |
| NCT04775355 |
Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer |
| NCT05391126 |
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
| NCT07332455 |
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC |
| NCT07095517 |
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors |
| NCT07023289 |
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease |
| NCT06332755 |
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC |
| NCT07090148 |
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC |
| NCT05704647 |
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases |
| NCT05376878 |
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis |
| NCT06270706 |
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors |
| NCT05840484 |
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance |
| NCT07100106 |
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer |
| NCT04700332 |
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer |
| NCT07594106 |
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma |
| NCT02016248 |
SBRT Boost for Unfavorable Prostate Cancer' |
| NCT05741164 |
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer |
| NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
| NCT06504147 |
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery |
| NCT06075524 |
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types |
| NCT06907446 |
Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies |
| NCT06774027 |
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer |
| NCT07504796 |
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab |
| NCT03877796 |
Clinical Pre-screening Protocol for Ovarian Cancer |
| NCT06850623 |
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer |
| NCT07084779 |
Investigation of Impact of AI on Prostate Cancer Workflow |
| NCT07231159 |
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots |
| NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT06252662 |
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies |
| NCT06910761 |
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer |
| NCT05323409 |
Improving Comprehensive Care of Cancer Patients |
| NCT06168487 |
Telmisartan in Prostate Cancer |
| NCT05748834 |
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
| NCT07525206 |
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer |
| NCT06169371 |
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) |
| NCT06150664 |
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies |
| NCT04354064 |
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors |
| NCT04893109 |
ATEMPT 2.0: Adjuvant T-DM1 vs TH |
| NCT06567314 |
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma |
| NCT06961006 |
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) |
| NCT04606914 |
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
| NCT02402244 |
Project: Every Child for Younger Patients With Cancer |
| NCT07335354 |
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery |
| NCT06927895 |
Breast Cancer Implementation Science Study With Educational Intervention |
| NCT06694181 |
Safe and Explainable AI |
| NCT06542757 |
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy |
| NCT06986083 |
A Study of Changes to Prostate Procedures |
| NCT07677267 |
A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan |
| NCT07209436 |
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction |
| NCT06795529 |
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer |
| NCT05770531 |
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy |
| NCT07276529 |
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses |
| NCT05029999 |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer |
| NCT06117241 |
Reducing Metabolic Dysregulation in Dyads |
| NCT05417594 |
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies |
| NCT07813637 |
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC |
| NCT07540572 |
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors |
| NCT04175431 |
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study |
| NCT05613894 |
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT06651580 |
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study |
| NCT07128927 |
Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors |
| NCT06224673 |
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer |
| NCT07505797 |
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health |
| NCT04221542 |
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT05487846 |
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation |
| NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
| NCT06861088 |
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer |
| NCT06267729 |
Study of AZD0754 in Participants With Metastatic Prostate Cancer |
| NCT07139977 |
Study of EV for Recurrent Endometrial Carcinoma |
| NCT06072807 |
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer |
| NCT06673329 |
Brodalumab in the Treatment of Immune-Related Adverse Events |
| NCT06625775 |
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors |
| NCT07636200 |
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer |
| NCT05376592 |
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma |
| NCT07140172 |
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery |
| NCT05902507 |
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer |
| NCT06586957 |
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors |
| NCT04981119 |
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing |
| NCT07481383 |
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer |
| NCT04903119 |
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma |
| NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
| NCT07389967 |
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer |
| NCT06517212 |
Tirzepatide Weight Loss for MRD+ Early Breast Cancer |
| NCT04575935 |
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial |
| NCT05020860 |
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer |
| NCT06067841 |
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer |
| NCT07335224 |
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture |
| NCT06378346 |
GU-01: Glycyrrhizin in Prostate Cancer |
| NCT06503146 |
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection |
| NCT07686250 |
Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery |
| NCT07550088 |
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases |
| NCT06949410 |
HER2 Vaccine for Locally Advanced Breast Cancer |
| NCT06966388 |
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation |
| NCT07054346 |
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 |
| NCT07303894 |
A Study of Isoquercetin in People With Ovarian Cancer |
| NCT04550845 |
Understanding of Genetics by Men at Risk for Prostate Cancer |
| NCT05155046 |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy |
| NCT06731894 |
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors |
| NCT06657222 |
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors |
| NCT05646862 |
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy |
| NCT07318805 |
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors |
| NCT06751329 |
A Study of DM002 in Patients With Advanced Solid Tumors |
| NCT07623941 |
CUIMC Focal Therapy Registry |
| NCT05921253 |
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy |
| NCT03965234 |
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases |
| NCT07117032 |
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain |
| NCT06726148 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors |
| NCT06830265 |
Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis |
| NCT07124000 |
DESTINY-PANTUMOUR04 |
| NCT07512271 |
Generative AI Patient Education Module for Breast Oncology |
| NCT07415564 |
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers |
| NCT07454499 |
Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE) |
| NCT06778863 |
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation |
| NCT05939414 |
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. |
| NCT07361614 |
Pilot Testing of a Colorectal Cancer Education Program |
| NCT06161506 |
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer |
| NCT03321045 |
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness |
| NCT04888975 |
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery |
| NCT05564377 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial |
| NCT02610439 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer |
| NCT04474301 |
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic |
| NCT05051722 |
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer |
| NCT06574880 |
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer |
| NCT07832617 |
Protoacoustic Imaging For 3D Mapping |
| NCT06576115 |
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer |
| NCT05691010 |
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer |
| NCT06217874 |
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer |
| NCT07489287 |
GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer |
| NCT05468034 |
Exercise in Metastatic Breast Cancer: EMBody |
| NCT04841148 |
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer |
| NCT06952504 |
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) |
| NCT07115914 |
PSMA PET for Surveillance After Focal Therapy |
| NCT07478016 |
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients |
| NCT04633252 |
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer |
| NCT05743621 |
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer |
| NCT07444814 |
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors |
| NCT04073706 |
Sentinel Node Biopsy in Endometrial Cancer |
| NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
| NCT07270237 |
A Study of Multiparametric Ultrasound Imaging Methods |
| NCT06517901 |
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer |
| NCT06536881 |
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming |
| NCT07201519 |
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy |
| NCT07405801 |
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer |
| NCT05517811 |
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection |
| NCT06479239 |
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer |
| NCT07080242 |
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors |
| NCT04513028 |
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma |
| NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
| NCT06063928 |
Confronting Cancer as a Community |
| NCT05123807 |
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) |
| NCT06833502 |
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer |
| NCT06504914 |
Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors |
| NCT07383506 |
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors |
| NCT07476001 |
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC |
| NCT06460298 |
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer |
| NCT06401421 |
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) |
| NCT06581406 |
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma |
| NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
| NCT05178498 |
Impact of Dietary Inflammatory Potential on Breast Cancer Risk |
| NCT06350500 |
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care |
| NCT07052214 |
PSMA PET Combined With MRI for the Detection of PCa |
| NCT07169734 |
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors |
| NCT06258993 |
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation |
| NCT05983432 |
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors |
| NCT07065552 |
Tirzepatide in Obesity-Driven Endometrial Cancer |
| NCT06557733 |
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis |
| NCT06428721 |
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population |
| NCT07519655 |
Phase 1 Study of PF-08046033 in Advanced Solid Tumors |
| NCT00899626 |
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients |
| NCT06084338 |
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc |
| NCT06840886 |
A Study of PHST001 in Advanced Solid Tumors |
| NCT06553885 |
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC |
| NCT07436078 |
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors |
| NCT06230185 |
CtDNA Based MRD Testing for NAC Monitoring in TNBC |
| NCT06062498 |
Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer |
| NCT07214298 |
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT07311993 |
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer |
| NCT07006727 |
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors |
| NCT00823654 |
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations |
| NCT06037954 |
A Study of Mental Health Care in People With Cancer |
| NCT07018869 |
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors |
| NCT04683679 |
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer |
| NCT06906341 |
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers |
| NCT05000294 |
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types |
| NCT06966024 |
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers |
| NCT03175224 |
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors |
| NCT05462496 |
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer |
| NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
| NCT07804186 |
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma |
| NCT01530373 |
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients |
| NCT06887205 |
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study |
| NCT03832361 |
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer |
| NCT07029399 |
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors |
| NCT07280715 |
Investigating Real-Time Immunotherapy Symptoms Study |
| NCT06409052 |
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women |
| NCT07296887 |
CARE Tool Study Aim 3 |
| NCT04729114 |
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer |
| NCT06953089 |
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors |
| NCT06270043 |
Focal Therapy for Localized Prostate Cancer |
| NCT03604315 |
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF |
| NCT06533826 |
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd |
| NCT06915025 |
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer |
| NCT07624617 |
Fast-Her: Fasting Effects on Breast Cancer Treatment |
| NCT06858449 |
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer |
| NCT05590949 |
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors |
| NCT07049055 |
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer |
| NCT06500481 |
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial |
| NCT05898399 |
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA) |
| NCT07200830 |
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial |
| NCT07136428 |
Asciminib in HER2+ Breast Cancer Brain Metastases |
| NCT05281471 |
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) |
| NCT06787612 |
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer |
| NCT06658912 |
Planning Grant for TOPS for Breast Cancer Survivors |
| NCT05242744 |
FTT PET/CT in Metastatic Prostate Cancer |
| NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
| NCT06549465 |
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) |
| NCT07249775 |
A First-in-Human Study of FID-022 in Solid Tumor Patients |
| NCT04020575 |
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
| NCT05144698 |
RAPA-201 Therapy of Solid Tumors |
| NCT06551116 |
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer |
| NCT05743517 |
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) |
| NCT03257033 |
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC |
| NCT04003038 |
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery |
| NCT07030348 |
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study |
| NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
| NCT07211178 |
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies |
| NCT02775643 |
Molecular Analysis of Childhood and Adolescent Melanocytic Lesions |
| NCT06817668 |
Evaluating Tolerability of ePUHRT With Brachytherapy Boost |
| NCT05534438 |
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer |
| NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
| NCT05691491 |
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness |
| NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
| NCT05463796 |
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer |
| NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
| NCT06136624 |
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) |
| NCT04297020 |
Brain Health in Breast Cancer Survivors |
| NCT05497024 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing |
| NCT06122896 |
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals |
| NCT06675643 |
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App |
| NCT06959550 |
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer |
| NCT06112990 |
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression |
| NCT06541210 |
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men |
| NCT07011576 |
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL) |
| NCT05704283 |
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer |
| NCT05903131 |
Uterine Preservation Via Lifestyle Transformation |
| NCT06748222 |
E-Mindfulness Approaches for Living After Breast Cancer |
| NCT06790693 |
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer |
| NCT07454603 |
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth |
| NCT06965192 |
Designing Visual Tools to Enhance Cancer Surgeon Decision-making |
| NCT06764771 |
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors |
| NCT07739563 |
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer |
| NCT07137416 |
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer |
| NCT06842498 |
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
| NCT06386887 |
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer |
| NCT06100263 |
Breast Cancer Resiliency Through Exercise Program (B-REP) |
| NCT06637306 |
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer |
| NCT06876714 |
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab |
| NCT06252649 |
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation |
| NCT05887609 |
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib |
| NCT06932757 |
Adjuvant Quisinostat in High-Risk Uveal Melanoma |
| NCT06910657 |
IDOV-Immune for Advanced Solid Tumors |
| NCT07675967 |
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study |
| NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
| NCT07066657 |
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors |
| NCT06795009 |
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer |
| NCT06657144 |
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors |
| NCT07184957 |
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer |
| NCT04114136 |
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies |
| NCT07578571 |
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer |
| NCT06751589 |
A Study of a Weight Loss Intervention in People With Endometrial Cancer |
| NCT05523947 |
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor |
| NCT07042243 |
The Florida ASCENT Study |
| NCT06148038 |
CBD for Breast Cancer Primary Tumors |
| NCT05190978 |
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction |
| NCT07443943 |
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial |
| NCT05379985 |
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS |
| NCT06281678 |
A Study of IBI363 in Subjects with Advanced Solid Malignancies |
| NCT07213674 |
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer |
| NCT07360314 |
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors |
| NCT06246968 |
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer |
| NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
| NCT05319314 |
LYL273 for Patients With Relapsed or Refractory mCRC |
| NCT06377852 |
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study |
| NCT07723248 |
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) |
| NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer |
| NCT07109726 |
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations |
| NCT05612347 |
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps |
| NCT06756932 |
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer |
| NCT06112314 |
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) |
| NCT04052048 |
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer |
| NCT06568016 |
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers |
| NCT07123649 |
Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study |
| NCT07619534 |
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases |
| NCT06343077 |
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance |
| NCT06856499 |
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer |
| NCT06228599 |
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence |
| NCT07647328 |
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer |
| NCT07341867 |
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype |
| NCT07768436 |
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer |
| NCT07280312 |
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions |
| NCT05856981 |
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors |
| NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer |
| NCT07224724 |
Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases |
| NCT05417308 |
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer |
| NCT07271017 |
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe |
| NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
| NCT07071896 |
A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors |
| NCT07391774 |
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial |
| NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
| NCT07067788 |
B.Brilliant Revelation Comparision Study |
| NCT06161025 |
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
| NCT05071937 |
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer |
| NCT07093177 |
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer |
| NCT06130995 |
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer |
| NCT04196257 |
BP1001-A in Patients With Advanced or Recurrent Solid Tumors |
| NCT07206056 |
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01) |
| NCT05534646 |
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
| NCT06058377 |
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer |
| NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
| NCT05863195 |
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial |
| NCT03740256 |
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors |
| NCT07174336 |
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) |
| NCT03384238 |
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery |
| NCT05996107 |
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer |
| NCT03484299 |
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
| NCT06663319 |
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers |
| NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
| NCT07307664 |
Increasing Germline Genetic Testing for Patients With Cancer |
| NCT06518564 |
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer |
| NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
| NCT01102556 |
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease |
| NCT06070012 |
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma |
| NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
| NCT06440005 |
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors |
| NCT07340541 |
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies |
| NCT05136196 |
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study |
| NCT06365905 |
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding |
| NCT07426822 |
Rash & Diarrhea Prophylaxis With Capivasertib |
| NCT06574022 |
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks |
| NCT06386146 |
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation |
| NCT07226427 |
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer |
| NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial |
| NCT05287451 |
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study |
| NCT06867822 |
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer |
| NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
| NCT02381990 |
MRI/Ultrasound Fusion Guided Prostate Cryotherapy |
| NCT05129605 |
Prostate Cancer Genetic Risk Evaluation and Screening Study |
| NCT05556473 |
F-Tryptophan PET/CT in Human Cancers |
| NCT06695845 |
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors |
| NCT06371768 |
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors |
| NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
| NCT05549297 |
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) |
| NCT07167446 |
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy |
| NCT06430541 |
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence |
| NCT06141031 |
Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma |
| NCT05103683 |
First in Human Study of TORL-1-23 in Participants With Advanced Cancer |
| NCT06686394 |
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) |
| NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) |
| NCT06353386 |
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) |
| NCT06478589 |
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors |
| NCT06705686 |
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer |
| NCT06130280 |
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer |
| NCT07203482 |
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation |
| NCT07040280 |
Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma |
| NCT05735080 |
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer |
| NCT06937996 |
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System- |
| NCT05654246 |
Susan G. Komen's ShareForCures |
| NCT05915442 |
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer |
| NCT06171269 |
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life |
| NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
| NCT04294927 |
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention |
| NCT05616650 |
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor |
| NCT05111561 |
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer |
| NCT07242118 |
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management |
| NCT06307548 |
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer |
| NCT04548817 |
Neurocutaneous Melanocytosis Registry |
| NCT01441089 |
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis |
| NCT07660055 |
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors |
| NCT03861676 |
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT |
| NCT07067138 |
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast) |
| NCT05519449 |
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) |
| NCT06864338 |
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test |
| NCT06999798 |
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial |
| NCT05142033 |
Avera Cancer Sequencing and Analytics Protocol (ASAP) |
| NCT04899908 |
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases |
| NCT07285057 |
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance |
| NCT04904757 |
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening |
| NCT05245500 |
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion |
| NCT06355336 |
Real World Prostate Cancer Registry |
| NCT07124611 |
A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer |
| NCT06605430 |
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer |
| NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
| NCT00756665 |
Prostate Active Surveillance Study |
| NCT05489211 |
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) |
| NCT07628634 |
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors |
| NCT07411599 |
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") |
| NCT06022822 |
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial |
| NCT07144228 |
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer |
| NCT07148128 |
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. |
| NCT05877599 |
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation |
| NCT05365581 |
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer |
| NCT02838836 |
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers |
| NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
| NCT07142967 |
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II) |
| NCT07199764 |
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer |
| NCT04567771 |
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer |
| NCT07220512 |
The Better, Harder, Faster, Stronger Study |
| NCT04858334 |
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation |
| NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
| NCT07158164 |
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment |
| NCT07417488 |
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas |
| NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
| NCT04545957 |
Jump: MR Simulation For Radiation Therapy Master Protocol |
| NCT04650256 |
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences |
| NCT07300995 |
Behavioral Pain Intervention for Older Cancer Patients |
| NCT06844383 |
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide |
| NCT05800665 |
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer |
| NCT04774419 |
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery |
| NCT04693377 |
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial |
| NCT07190300 |
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
| NCT06792695 |
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer |
| NCT06971744 |
Autophagy Maintenance (AUTOMAIN) |
| NCT06205836 |
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer |
| NCT06815354 |
Comprehensive Assessment of Cancer Theranostic Response |
| NCT06073431 |
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia |
| NCT07226154 |
Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer |
| NCT05113537 |
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
| NCT05077137 |
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy |
| NCT05379595 |
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer |
| NCT06500169 |
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors |
| NCT07745361 |
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer |
| NCT05579366 |
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
| NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
| NCT06728072 |
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer |
| NCT05134779 |
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You |
| NCT06276491 |
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
| NCT06223659 |
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers |
| NCT06385925 |
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation |
| NCT07550517 |
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT |
| NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
| NCT07020117 |
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors |
| NCT06780176 |
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida |
| NCT06534918 |
Precise Oncology Interventions in Nutrition and Training (OnPoint) |
| NCT06312124 |
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer |
| NCT07281924 |
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis |
| NCT05655494 |
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials |
| NCT06917079 |
BBO-11818 in Adult Subjects With KRAS Mutant Cancer |
| NCT07341503 |
The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients |
| NCT07189403 |
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer |
| NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
| NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
| NCT06165302 |
Exercise in Prostate Cancer |
| NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
| NCT07071961 |
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] |
| NCT06202183 |
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial |
| NCT06915168 |
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer |
| NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
| NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
| NCT05562791 |
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer |
| NCT03334708 |
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma |
| NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
| NCT07647250 |
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy |
| NCT06184750 |
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial |
| NCT04603209 |
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer |
| NCT05038332 |
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) |
| NCT04990609 |
EUS-RFA PANCARDINAL-1 Trial |
| NCT07032584 |
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer |
| NCT07218432 |
A Study of the TheraBionic P1 Device in Breast Cancer |
| NCT06260033 |
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer |
| NCT06418204 |
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics |
| NCT04516447 |
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer |
| NCT01185132 |
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy |
| NCT05914116 |
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
| NCT06855706 |
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study |
| NCT06612281 |
Evaluation of Gixam's Performance in a FIT Negative Population |
| NCT05647564 |
PET/CT Characterization of Treatment Resistance |
| NCT05501704 |
ETHAN - ET for Male BC |
| NCT06598007 |
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors |
| NCT06139107 |
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole |
| NCT05478694 |
Outcomes of Focal Ablation for Prostate Cancer |
| NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
| NCT06888388 |
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer |
| NCT05899361 |
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest |
| NCT06318897 |
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer |
| NCT07043270 |
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC |
| NCT05568550 |
Pembro With Radiation With or Without Olaparib |
| NCT05627960 |
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
| NCT01900821 |
National Mammography Database |
| NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. |
| NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
| NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
| NCT07192432 |
Gene Therapy for HER-Positive Cancer (SENTRY-HER2) |
| NCT06487507 |
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS) |
| NCT04787744 |
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer |
| NCT07672119 |
A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide |
| NCT06941857 |
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer |
| NCT05837455 |
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer |
| NCT06439693 |
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer |
| NCT07458347 |
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation |
| NCT07543055 |
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread |
| NCT06049355 |
EMBRACE: Exercising Together |
| NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
| NCT06964009 |
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer |
| NCT07076485 |
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer |
| NCT06366347 |
ALPINE: Maintenance Letrozole/Abemaciclib |
| NCT07432633 |
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications |
| NCT06745895 |
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening |
| NCT04239573 |
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers |
| NCT07824583 |
A Study Evaluating a New Radiation Treatment Workflow (NGDS) |
| NCT03408353 |
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study |
| NCT07077239 |
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity |
| NCT06580002 |
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial |
| NCT06194929 |
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma |
| NCT03418961 |
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity |
| NCT07237269 |
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer |
| NCT06634875 |
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) |
| NCT04916990 |
Improving Care for Rural Patients With Solid Tumors |
| NCT04658303 |
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma |
| NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |
| NCT06961955 |
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer |
| NCT02620852 |
Women Informed to Screen Depending on Measures of Risk (Wisdom Study) |
| NCT06398418 |
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors |
| NCT06896474 |
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers |
| NCT03819296 |
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer |
| NCT07143487 |
Family Communications After Genetic Testing |
| NCT05505643 |
Cryoablation vs Lumpectomy in T1 Breast Cancers |
| NCT06824818 |
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients |
| NCT05979610 |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies |
| NCT06400550 |
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis |
| NCT06639074 |
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial |
| NCT06925724 |
A Study of Ivonescimab in People With Endometrial and Cervical Cancers |
| NCT05590624 |
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer |
| NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
| NCT06989112 |
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer |
| NCT05386719 |
Cardiometabolic Screening Program |
| NCT07604571 |
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer |
| NCT06056830 |
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy |
| NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
| NCT06476808 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. |
| NCT07055165 |
Connect2Care: Prostate Cancer Education and Screenings for African American Men |
| NCT07563738 |
A 2-part Phase 1/2 Open-label Trial on ODM-212 |
| NCT06542835 |
Community Partnership for Telehealth Solutions to Convey Information and Enhance Care |
| NCT04589468 |
Researching the Effect of Exercise on Cancer |
| NCT06682390 |
Role of Race in Nutritional Approach in Men on ADT |
| NCT07746713 |
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer |
| NCT07220018 |
Colorectal Cancer Screening in the Homeless |
| NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
| NCT07403981 |
Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients |
| NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
| NCT06327490 |
A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer |
| NCT07619313 |
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer |
| NCT07634380 |
Sitagliptin With Pembro in RCC and Melanoma |
| NCT06788886 |
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases |
| NCT04701476 |
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC |
| NCT07495124 |
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence |
| NCT07182279 |
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer |
| NCT06934538 |
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer |
| NCT05743049 |
Collection of Circulating Biomarkers in Pancreatic Cancer |
| NCT06952803 |
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation |
| NCT06389097 |
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization |
| NCT06202820 |
CV CARE: CardioVascular Care in PC Patients |
| NCT00539162 |
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women |
| NCT07361562 |
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors |
| NCT06835569 |
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations |
| NCT05930483 |
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial |
| NCT01000259 |
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer |
| NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
| NCT07164456 |
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers |
| NCT07524322 |
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors |
| NCT06609005 |
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer |
| NCT05559879 |
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma |
| NCT02393703 |
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer |
| NCT07690852 |
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care |
| NCT07038785 |
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs |
| NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
| NCT06262139 |
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients |
| NCT06153836 |
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction |
| NCT05225428 |
Video Education With Result Dependent dIsclosure |
| NCT05768139 |
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
| NCT06960707 |
Two Versus One Week Breast Radiotherapy (RT) |
| NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
| NCT06806930 |
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) |
| NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases |
| NCT05726292 |
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer |
| NCT07690917 |
A Study of a New PET Scanner in People With Cancer |
| NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
| NCT06665945 |
The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer |
| NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
| NCT07020221 |
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors |
| NCT07079631 |
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer |
| NCT02328677 |
ColoCare Study - Colorectal Cancer Cohort |
| NCT02896335 |
Palbociclib and Pembrolizumab In Central Nervous System Metastases |
| NCT06959537 |
A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC) |
| NCT04406831 |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer |
| NCT07130708 |
Exploring the Potential of Robotic Telesurgery in Remote Settings |
| NCT07652242 |
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer |
| NCT07419841 |
A Phase 1 Study of the Safety and Tolerability of CTX-10726 |
| NCT07444541 |
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer |
| NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
| NCT06677112 |
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer |
| NCT06771544 |
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma |
| NCT05304858 |
Tumor Microenvironment Analysis of Prostate Cancer Metastasis |
| NCT06451497 |
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors |
| NCT06926920 |
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer |
| NCT07416552 |
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC) |
| NCT07502352 |
Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM) |
| NCT05868226 |
PRE-ISPY Phase I/II Oncology Platform Program |
| NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
| NCT07685938 |
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease |
| NCT05687188 |
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations |
| NCT03854110 |
A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine |
| NCT07555210 |
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy |
| NCT05752448 |
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) |
| NCT06085313 |
Cancer Pain Management Using a Web-based Intervention |
| NCT00488878 |
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors |
| NCT06044025 |
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy |
| NCT07308717 |
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol |
| NCT05665738 |
Two-fraction HDR Monotherapy for Localized Prostate Cancer |
| NCT04969315 |
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma |
| NCT06943755 |
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors |
| NCT05903885 |
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans |
| NCT07015190 |
Neoadjuvant Darovasertib in Primary Uveal Melanoma |
| NCT06111313 |
The University of Miami Adapt (UAdapt) Trial |
| NCT06039085 |
Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment |
| NCT07544589 |
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers |
| NCT06843447 |
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) |
| NCT06095089 |
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer |
| NCT04489238 |
Collection of Information to Better Understand Young Onset Colorectal Cancer |
| NCT07817147 |
CREO - Microwave Ablation Feasibility Study |
| NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer |
| NCT06764940 |
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases |
| NCT07447050 |
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial |
| NCT06666790 |
DermaSensor Postmarket Surveillance Study |
| NCT06216249 |
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) |
| NCT06318507 |
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy |
| NCT07120100 |
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors |
| NCT06908928 |
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs |
| NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
| NCT07125209 |
Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers |
| NCT07218250 |
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer |
| NCT05790213 |
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation |
| NCT06983743 |
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors |
| NCT07222215 |
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) |
| NCT06557057 |
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk |
| NCT06563388 |
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial |
| NCT07244341 |
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| NCT03539822 |
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies |
| NCT07393867 |
Androgen-responsive POSLUMA-guided Intra-prostatic Boost |
| NCT06008275 |
Neratinib in Combination With Ruxolitinib in Patients With mTNBC |
| NCT05455619 |
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer |
| NCT03860883 |
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma |
| NCT06617481 |
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence |
| NCT05429970 |
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) |
| NCT06040541 |
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors |
| NCT01950572 |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma |
| NCT01365169 |
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" |
| NCT07833566 |
Biopsy-site-marker in Breast Cancer |
| NCT06228053 |
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer |
| NCT04701645 |
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer |
| NCT07218809 |
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer |
| NCT04985032 |
Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) |
| NCT05595499 |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
| NCT07220863 |
Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai |
| NCT07158021 |
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial |
| NCT07487844 |
Pulsed Electric Field Ablation for Metastatic Breast Cancer |
| NCT06626516 |
Tebentafusp-tebn With LDT in Metastatic UM |
| NCT07549412 |
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) |
| NCT07736937 |
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer |
| NCT02478892 |
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk |
| NCT04868604 |
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) |
| NCT06065371 |
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy |
| NCT03659448 |
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer |
| NCT06408298 |
HCQ in Resectable Localized Prostate Cancer |
| NCT06145633 |
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer |
| NCT07426952 |
Weight Management After Cancer for Survivors in Rural Communities |
| NCT07228832 |
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer |
| NCT07282158 |
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians |
| NCT05723107 |
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT05989347 |
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy |
| NCT00923221 |
Collection of Blood From Patients With Prostate Cancer |
| NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
| NCT07219238 |
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) |
| NCT05361798 |
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy |
| NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
| NCT07383649 |
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection |
| NCT06813898 |
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial |
| NCT05132504 |
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer |
| NCT05321134 |
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery |
| NCT06878131 |
Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease |
| NCT06906562 |
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations |
| NCT05373823 |
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors |
| NCT07112053 |
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer |
| NCT06295159 |
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma |
| NCT06785441 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing |
| NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
| NCT06200259 |
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement |
| NCT07492927 |
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer |
| NCT06710288 |
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer |
| NCT05919329 |
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy |
| NCT07147231 |
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer |
| NCT07542041 |
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens |
| NCT04275557 |
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| NCT03322995 |
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial |
| NCT07413939 |
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive |
| NCT04300556 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types |
| NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers |
| NCT02706561 |
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery |
| NCT03396341 |
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes |
| NCT07318051 |
Sample Collection for Ongoing Research and Product Evaluation Study |
| NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
| NCT03954431 |
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT) |
| NCT00899301 |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
| NCT05379153 |
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial |
| NCT05985655 |
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors |
| NCT06600698 |
Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA |
| NCT04792684 |
Collection of Samples USOPTIVAL Study |
| NCT07293585 |
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment |
| NCT06616155 |
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
| NCT07109817 |
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer |
| NCT07208084 |
Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer |
| NCT07562152 |
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma |
| NCT06199713 |
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients |
| NCT02302742 |
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry |
| NCT06662786 |
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer |
| NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
| NCT06885203 |
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI) |
| NCT06636682 |
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
| NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
| NCT04946370 |
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer |
| NCT06439979 |
Rural Adult and Youth Sun Protection Study |
| NCT06898333 |
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening |
| NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
| NCT06797635 |
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) |
| NCT07459673 |
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission |
| NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
| NCT06875128 |
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease |
| NCT05669430 |
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies |
| NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
| NCT06995924 |
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education |
| NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
| NCT03796559 |
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes |
| NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
| NCT05932862 |
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors |
| NCT06369259 |
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer |
| NCT07216560 |
First-in-human Study of 7MW4911 in GI Cancer |
| NCT07831824 |
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup]) |
| NCT01034033 |
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples |
| NCT07460752 |
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients |
| NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
| NCT07528638 |
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND) |
| NCT04174352 |
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer |
| NCT06565052 |
The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial |
| NCT04468061 |
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC |
| NCT06369246 |
PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer. |
| NCT00353483 |
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells |
| NCT06414590 |
Neoadjuvant Tebentafusp for Uveal Melanoma |
| NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
| NCT07069556 |
ColoSense Post-Approval Study |
| NCT07084168 |
Multimedia Aid for Genetic Testing in Gynecologic Oncology |
| NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
| NCT06705803 |
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE) |
| NCT06303505 |
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC |
| NCT06496256 |
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial |
| NCT07718854 |
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer |
| NCT07220239 |
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome |
| NCT03686124 |
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors |
| NCT06783179 |
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement |
| NCT05864196 |
Two Fraction Prostate SBRT With DIL SIB |
| NCT06334354 |
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC) |
| NCT07207564 |
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk |
| NCT02621021 |
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab |
| NCT05296421 |
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer |
| NCT06165419 |
Definitive Radiation for High-Risk Spine Metastases |
| NCT06759701 |
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study |
| NCT07360119 |
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors |
| NCT06683755 |
Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY) |
| NCT07262619 |
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors |
| NCT05052671 |
ctDNA Assay in Patients With Resectable Pancreatic Cancer |
| NCT05088798 |
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism |
| NCT04594187 |
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma |
| NCT02997293 |
Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery |
| NCT06639724 |
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer |
| NCT06672302 |
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer |
| NCT05095207 |
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer |
| NCT07631572 |
Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer |
| NCT06675357 |
Using FAPI PET/MRI to Evaluate Prostate Cancer |
| NCT06938581 |
ERAS Protocols in Breast Conserving Surgery |
| NCT06395519 |
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies |
| NCT06833866 |
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer |
| NCT06998407 |
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors |
| NCT05941507 |
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors |
| NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
| NCT07801664 |
Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer |
| NCT06378866 |
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial |
| NCT07173751 |
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer |
| NCT04633239 |
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer |
| NCT06520345 |
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) |
| NCT06158139 |
Autologous CAR-T Cells Targeting B7-H3 in PDAC |
| NCT07805954 |
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma |
| NCT05608694 |
MRI Screening in Men at High Risk of Developing Prostate Cancer |
| NCT07189195 |
TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma |
| NCT06904365 |
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women |
| NCT06666192 |
The Ohio State University (OSU) SCREEN Community Program |
| NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
| NCT04992728 |
Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI |
| NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
| NCT06972875 |
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer |
| NCT06263088 |
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. |
| NCT06646627 |
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors |
| NCT07546331 |
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction |
| NCT07651358 |
A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy |
| NCT06897488 |
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial |
| NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
| NCT06843551 |
The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation |
| NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
| NCT04986423 |
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer |
| NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
| NCT05056857 |
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen |
| NCT05126290 |
CTNNA1 Familial Expansion Study |
| NCT06917313 |
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy |
| NCT07094113 |
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors |
| NCT07424547 |
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors |
| NCT03564340 |
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
| NCT06058650 |
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities |
| NCT07698535 |
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial |
| NCT06472661 |
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma |
| NCT07751042 |
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
| NCT04048278 |
Lidocaine Infusion in Pancreatic Cancer |
| NCT04585750 |
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) |
| NCT06922591 |
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients |
| NCT07733674 |
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT05603910 |
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma |
| NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
| NCT07699991 |
A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors |
| NCT03474913 |
Upright MRI for Prostate Cancer Screening |
| NCT06545942 |
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors |
| NCT04434040 |
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) |
| NCT07629960 |
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations |
| NCT02926690 |
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer |
| NCT07711847 |
Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy |
| NCT07594626 |
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion |
| NCT06253871 |
A Phase 1/1b Study of IAM1363 in HER2 Cancers |
| NCT07033026 |
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. |
| NCT05372614 |
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene |
| NCT06246916 |
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) |
| NCT04991948 |
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer |
| NCT04706663 |
Precision-Based Genomics in Prostate Cancer |
| NCT07235293 |
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. |
| NCT06064149 |
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study |
| NCT06625034 |
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer |
| NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. |
| NCT04486352 |
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer |
| NCT07478185 |
Prehab for Pancreatic Cancer Surgery |
| NCT07427043 |
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES) |
| NCT06773897 |
Rutgers University Study of the Genetics of Breast Cancer. |
| NCT07318324 |
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer |
| NCT07690579 |
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities |
| NCT03897270 |
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects |
| NCT05011383 |
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers |
| NCT07087054 |
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen |
| NCT07812805 |
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors |
| NCT07755436 |
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. |
| NCT07225036 |
Promoting Immunotherapy Efficacy With Low-Dose Liver RT |
| NCT03340506 |
Dabrafenib and/or Trametinib Rollover Study |
| NCT07059884 |
Distance-Based Exercise to Preserve Function and Prevent Disability |